| Date | Form | Description | Docs | XBRL | Pages |
| 01/14/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/10/20 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
110 | |
| 01/09/20 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
4 | |
| 01/09/20 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
128 |
| 12/16/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/16/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/04/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/24/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/24/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/24/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences Announces Licensing Agreement with Cleveland Clinic for Ovarian Cancer Vaccine Technology
Read More...Anixa Biosciences and Cleveland Clinic File IND Application for Breast Cancer Vaccine
Read More...Anixa Biosciences to Host Conference Call to Provide Update on Programs
Read More...